<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-7026</journal-id>
<journal-title><![CDATA[Psicología, Conocimiento y Sociedad]]></journal-title>
<abbrev-journal-title><![CDATA[Psicol. Conoc. Soc.]]></abbrev-journal-title>
<issn>1688-7026</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Psicología. Universidad de la República]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-70262018000200053</article-id>
<article-id pub-id-type="doi">10.26864/pcs.v8.n2.5</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[&#8220;Drogas da Inteligência?&#8221;: Cartografando as controvérsias do consumo da Ritalina® para o aprimoramento cognitivo]]></article-title>
<article-title xml:lang="es"><![CDATA[&#8220;¿Drogas de la Inteligencia?&#8221;: Cartografando las controversias del consumo de la Ritalina® para el mejoramiento cognitivo]]></article-title>
<article-title xml:lang="en"><![CDATA[&#8220;Smart Drugs?&#8221;: Mapping the controversies on the use of Ritalin® for cognitive enhancement]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[Cristiana de Siqueira]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pedro]]></surname>
<given-names><![CDATA[Rosa Maria Leite Ribeiro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidade Federal do Rio de Janeiro  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>8</volume>
<numero>2</numero>
<fpage>53</fpage>
<lpage>67</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-70262018000200053&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-70262018000200053&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-70262018000200053&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: O consumo da Ritalina® para o aprimoramento cognitivo vem aumentando no Brasil e no mundo, atraindo a atenção de diversos estudiosos que vêm discutindo as questões éticas envolvidas nesse consumo, denominado off-label, que ainda portam muitas controvérsias. O presente artigo apresenta algumas controvérsias referentes aos riscos e efeitos do consumo da Ritalina para fins de aprimoramento cognitivo, bem como as expectativas em relação ao futuro desse consumo. Para tanto, foi realizada uma pesquisa na qual foram entrevistados psiquiatras, propagandistas da indústria farmacêutica e consumidores destes medicamentos. Os resultados apontam para a centralidade do respaldo médico ao consumo, o que converge para as análises voltadas para a medicalização e farmaceuticalização da sociedade contemporânea; e para a prevalência da performance sobre o risco, em sintonia com os valores próprios à atualidade.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: El consumo de la Ritalin® para el mejoramiento cognitivo viene aumentando en Brasil y en el mundo, atrayendo la atención de varios estudiosos que vienen discutiendo las cuestiones éticas acerca de ese consumo, llamado off-label, que todavía genera muchas controversias. El presente artículo presenta algunas de esas controversias relativas a los riesgos y efectos del consumo de la Ritalina para fines del mejoramiento cognitivo, así como las expectativas en relación a ese consumo. Para ello, fue realizada una investigación en la cual se entrevistó a psiquiatras, propagandistas de la industria farmacéutica y consumidores de estos medicamentos. Los resultados apuntan a la responsabilidad al respaldo médico del consumo, lo que converge en el sentido de los análisis de la medicalización y farmaceuticalización de la sociedad contemporánea; y al predominio de la performance sobre el riesgo, en sintonía con los valores propios de la actualidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Ritalin® consumption for cognitive enhancement has been increasing in Brazil and in the world, attracting the attention of several scholars who have been discussing the ethical issues involved in this consumption, called off-label, which still carry many controversies. This article presents some controversies regarding the risks and effects of Ritalin consumption for the purpose of cognitive enhancement, as well as the expectations regarding the future of this consumption. To do so, a survey was conducted in which psychiatrists, pharmaceutical industry propagandists and consumers of these drugs were interviewed. The results point to the centrality of medical support to consumption, which converges to the concepts of medicalization and pharmaceuticalization, used to characterized contemporary society; and also to the prevalence of performance over risk, in line with current values.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Ritalina]]></kwd>
<kwd lng="pt"><![CDATA[Biotecnologias]]></kwd>
<kwd lng="pt"><![CDATA[Medicamentos psicotrópicos]]></kwd>
<kwd lng="pt"><![CDATA[Cartografia das controvérsias]]></kwd>
<kwd lng="es"><![CDATA[Ritalina]]></kwd>
<kwd lng="es"><![CDATA[Biotecnologías]]></kwd>
<kwd lng="es"><![CDATA[Psicofármacos]]></kwd>
<kwd lng="es"><![CDATA[Cartografía de las controversias]]></kwd>
<kwd lng="en"><![CDATA[Ritalin]]></kwd>
<kwd lng="en"><![CDATA[Biotechnology]]></kwd>
<kwd lng="en"><![CDATA[Psychotropic medications]]></kwd>
<kwd lng="en"><![CDATA[Cartography of controversies]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blech]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Figueiredo]]></surname>
<given-names><![CDATA[Magda Biggote de]]></given-names>
</name>
</person-group>
<source><![CDATA[Os inventores de doenças: uma denuncia corajosa e documentada sobre os abusos da indústria farmacêutica]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[Ambar]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brant]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metilfenidato: medicamento gadget da contemporaneidade]]></article-title>
<source><![CDATA[Interface - Comunicação, Saúde, Educação]]></source>
<year>2012</year>
<volume>16</volume>
<numero>42</numero>
<issue>42</issue>
<page-range>623-36</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caliman]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A constituição sócio-médica do &#8220;fato TDAH&#8221;]]></article-title>
<source><![CDATA[Psicologia &amp; Sociedade]]></source>
<year>2009</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>135-44</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chatterjee]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is it acceptable for people to take methylphenidade to enhance performance?]]></article-title>
<source><![CDATA[British Medical Journal]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Mamo]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Fosket]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fishman]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine]]></article-title>
<source><![CDATA[American Sociological Review]]></source>
<year>2003</year>
<volume>68</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>161-94</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clements]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hepburn]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Goldman]]></surname>
<given-names><![CDATA[J.,]]></given-names>
</name>
<name>
<surname><![CDATA[Osborn]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Klayman]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Take your pills]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Estados Unidos ]]></publisher-loc>
<publisher-name><![CDATA[Netflix, Motto Pictures]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coelho]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psicofármaco e sua magia: metilfenidato e desempenho]]></source>
<year>2014</year>
<conf-name><![CDATA[ 29ª Reunião Brasileira de Antropologia: Diálogos antropológicos expandindo fronteiras]]></conf-name>
<conf-loc>Natal </conf-loc>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conrad]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[The medicalization of society]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Baltimore ]]></publisher-loc>
<publisher-name><![CDATA[The John Hopkins University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dalibert]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Posthumanism and somatechnologies: exploring the intimate relations between humans and technologies]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Enschede ]]></publisher-loc>
<publisher-name><![CDATA[University of Twente]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domitrovic]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<source><![CDATA[As Práticas Farmacológicas com o Metilfenidato: habitando fronteiras entre o acesso e o excesso]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Espírito Santo ]]></publisher-loc>
<publisher-name><![CDATA[Universidade Federal do Espírito Santo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dumit]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Drugs for life: how farmaceutical companies define our health]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Durham and London ]]></publisher-loc>
<publisher-name><![CDATA[Duke University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Esposito]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethical Implications of Pharmacological Enhancement of Mood and Cognition]]></article-title>
<source><![CDATA[Penn Bioethics Journal]]></source>
<year>2005</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frize]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A debate on the ethitcs of body enhancement Technologies and regeneration]]></article-title>
<source><![CDATA[Engineering Dimisions]]></source>
<year>2013</year>
<page-range>52-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greely]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Sahakian]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kessler]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Towards responsible use of cognitive-enhancing drugs by the healthy]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2008</year>
<page-range>702-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is it acceptable for people to take methylphenidade to enhance performance?]]></article-title>
<source><![CDATA[British Medical Journal]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Da depressão ao transtorno de déficit de atenção/hiperatividade: estudo sobre a produção publicitária da Ritalina]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Rio Grande do Sul ]]></publisher-loc>
<publisher-name><![CDATA[Universidade Federal do Rio Grande do Sul]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Latour]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Reagregando o social: uma introdução à teoria do Ator-Rede]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Salvador ]]></publisher-loc>
<publisher-name><![CDATA[Edufba]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biopsiquiatria e bioidentidade: Política da subjetividade contemporânea]]></article-title>
<source><![CDATA[Psicologia &amp; Sociedade]]></source>
<year>2008</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>331-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mota]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Pessanha]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalência do uso do metilfenidato por universitários de Campos dos Goytakazes, RJ]]></article-title>
<source><![CDATA[VÉRTICES]]></source>
<year>2014</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>77-86</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Caliman]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Itaborahy]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Junqueira]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A ritalina no Brasil: produções, discursos e práticas]]></article-title>
<source><![CDATA[Interface - Comunicação, Saúde, Educação]]></source>
<year>2010</year>
<volume>14</volume>
<numero>34</numero>
<issue>34</issue>
<page-range>499-510</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vera]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A nova onda dos remédios para o cérebro: Mais e mais pessoas estão tomando drogas para aumentar a concentração e tentar ficar mais inteligentes. Que consequências isso pode ter?]]></article-title>
<source><![CDATA[Revista Época]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Gabe]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The pharmaceuticalisation of society ? A framework for analysis]]></article-title>
<source><![CDATA[Sociology of Heath y Illness]]></source>
<year>2011</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>710-25</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
